SCHEMBL6664087

SCHEMBL6664087

C(=CN1CCCCC1)Cc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.60
MAOB P27338 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.47
NPC1 O15118 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
RAB9A P51151 1/20 0.46
HPGD P15428 2/20 0.46
TSHR P16473 2/20 0.46
SIGMAR1 Q99720 2/20 0.46
MAPT P10636 4/20 0.44
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
NR4A1 P22736 1/20 0.44
SLC6A3 Q01959 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
ARG2 P78540 1/20 0.42
LMNA P02545 1/20 0.41
LTA4H P09960 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664094 0.98 MAPK1 (0.62) MAPK1MAOBL3MBTL1NPC1SMN1; SMN2
SCHEMBL15684281 0.81 SIGMAR1 (0.52) L3MBTL1NPC1SMN1; SMN2RAB9AHPGD
SCHEMBL1616064 0.81 MAPK1 (0.57) MAPK1MAOBTSHRSIGMAR1ALDH1A1
SCHEMBL1616428 0.81 MAPK1 (0.57) MAPK1MAOBL3MBTL1SIGMAR1MAPT
SCHEMBL1616066 0.81 MAPK1 (0.57) MAPK1MAOBTSHRSIGMAR1ALDH1A1
SCHEMBL6666145 0.81 MAPK1 (0.57) MAPK1MAOBL3MBTL1NPC1SMN1; SMN2
SCHEMBL1616429 0.81 MAPK1 (0.57) MAPK1MAOBL3MBTL1SIGMAR1MAPT
SCHEMBL12230208 0.80 MAPK1 (0.52) MAPK1L3MBTL1TSHRMAPTALDH1A1
SCHEMBL949223 0.79 TSHR (0.48) MAPK1MAOBL3MBTL1NPC1SMN1; SMN2
SCHEMBL945418 0.77 MAOB (0.48) MAPK1MAOBL3MBTL1NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111499558-B Asymmetric reduction method of chiral spiro-bis-boron catalytic substituted pyridine and application thereof 南开大学 2022-10-18 CN disclosed
CN-111499558-A Asymmetric reduction method for chiral spiro-bisboron catalyzed substituted pyridine and application thereof 南开大学 2020-08-07 CN disclosed
WO-2004024684-A2 ENANTIOSELECTIVE AMINATION AND ETHERIFICATION YALE UNIVERSITY (US) 2004-03-25 WO disclosed
US-4652572-A HISTAMINE H2-ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1987-03-24 US disclosed
US-4547512-A HISTAMINE H2-ANTAGONIST SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-10-15 US disclosed
EP-0065825-B1 PYRIDINE DERIVATIVES AS HISTAMINE H2 ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-06-19 EP disclosed
US-4439437-A 2-[2-Thiazolyl or 2-guanidino-4-thiazolyl methylthioethyl(or butyl)amino]-3-(hydroxy or carboxy)pyridines, compositions containing same and method of use SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1984-03-27 US disclosed
EP-0065825-A1 Pyridine derivatives as histamine H2 antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1982-12-01 EP disclosed